Kuperman S

Language: Spanish
References: 9
Page: 56-58
PDF size: 130.70 Kb.

Text Extraction

No abstract.

REFERENCES

1. Custer B, Kessler D, Vahidnia F, Leparc G, Krysztof DE, Shaz B et al.Risk factors for retrovirus and hepatitis virus infections in acceptedblood donors. Transfusion. 2015; 55 (5): 1098-1107. doi: 10.1111/trf.12951.

2. Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J.Estimating per-act HIV transmission risk: a systematic review.AIDS. 2014; 28 (10): 1509-1519. doi: 10.1097/QAD.0000000000000298.

3. Lewin A, Goldman M, Busch MP, Davison K, van de Laar T,Tiberghien P et al. End of selection criteria based on sexualorientation: an international symposium on alternatives todonation deferral. Vox Sang. 2024; 119 (4): 388-401. doi: 10.1111/vox.13587.

4. Organización Panamericana de la Salud. Elegibilidad para ladonación de sangre: recomendaciones para la educación y laselección de donantes potenciales de sangre. Actualización.Washington, DC: OPS; 2025.

5. Custer B, Quiner C, Haaland R, Martin A, Stone M, Reik R et al. HIVantiretroviral therapy and prevention use in US blood donors: anew blood safety concern. Blood. 2020; 136 (11): 1351-1358. doi:10.1182/blood.2020006890.

6. Elliott T, Sanders EJ, Doherty M, Ndung’u T, Cohen M, Patel P etal. Challenges of HIV diagnosis and management in the contextof PrEP, PEP, test and start and acute HIV infection: a scopingreview. J Int AIDS Soc. 2019; 22 (12): e25419. doi: 10.1002/jia2.25419.

7. Buccheri R, Warden DE, Oikawa M, Grebe E, Miranda C, AmorimL et al. Assessing HIV trends among blood donors in five Brazilianblood centers: the impact of individual donor assessment.Transfusion. 2025; 65 (4): 685-695. doi: 10.1111/trf.18168.

8. Goel R, Bravo M, Townsend M, Hopkins C, Vassallo R. Individualdonor assessment in the United States: impact on deferral andinfectious disease marker rates. Transfusion. 2026; 66 (3): 534-542.doi: 10.1111/trf.70085.

9. Joint United Kingdom Blood Transfusion and Tissue TransplantationServices Professional Advisory Committee. Position statement ontransgender and non-binary donors. London: JPAC; 2024.